# Immunotherapy of Hepatocellular Carcinoma With Gamma Delta T Cells

> **NCT00562666** · PHASE1 · TERMINATED · sponsor: **Rennes University Hospital** · enrollment: 2 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **OTHER:** T gamma delta lymphocytes

## Key facts

- **NCT ID:** NCT00562666
- **Lead sponsor:** Rennes University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-02
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2012-06-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00562666

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00562666, "Immunotherapy of Hepatocellular Carcinoma With Gamma Delta T Cells". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00562666. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*